UPDATE 1-China's drug regulator accepts Novo Nordisk's application for oral Wegovy

(Adds context on China market and Lilly and Novo approvals in paragraphs 1-7) SHANGHAI, Aug 27 (Reuters) – Novo Nordisk said on Thursday that China's drug regulator had accepted its application to

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)